AAAAAA

   
Results: 1-9 |
Results: 9

Authors: AZZOLI CG SAGAR M WU A LOWRY D HENNINGS H MORGAN DL WEINBERG WC
Citation: Cg. Azzoli et al., COOPERATION OF P53 LOSS OF FUNCTION AND V-HA-RAS IN TRANSFORMATION OFMOUSE KERATINOCYTE CELL-LINES, Molecular carcinogenesis, 21(1), 1998, pp. 50-61

Authors: SAGAR M SEENSALU R TYBRING G DAHL ML BERTILSSON L
Citation: M. Sagar et al., CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED WITH OMEPRAZOLE IN PATIENTSWITH ACID-RELATED DISORDERS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION, Scandinavian journal of gastroenterology, 33(10), 1998, pp. 1034-1038

Authors: SJOSTEDT S SAGAR M LINDBERG G WIKSTROM B NORD CE SEENSALU R
Citation: S. Sjostedt et al., PROLONGED AND PROFOUND ACID INHIBITION IS CRUCIAL IN HELICOBACTER-PYLORI TREATMENT WITH A PROTON PUMP INHIBITOR COMBINED WITH AMOXICILLIN, Scandinavian journal of gastroenterology, 33(1), 1998, pp. 39-43

Authors: SAGAR M TYBRING G DAHL ML BERTILSSON L SEENSALU R
Citation: M. Sagar et al., THE EFFECT OF OMEPRAZOLE ON INTRAGASTRIC PH AND GASTRIN-LEVELS IS DETERMINED BY THE CYP2C19 POLYMORPHISM MORE THAN BY HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH ACID-RELATED DISEASE, Gastroenterology, 114(4), 1998, pp. 1122-1122

Authors: SAGAR M BERTILSSON L DAHL ML TYBRING G SEENSALU R
Citation: M. Sagar et al., INDIVIDUAL METABOLISM OF OMEPRAZOLE IS DETERMINED BY THE GENOTYPE OF THE ENZYME CYP2C19 WITHOUT RELATION TO HELICOBACTER-PYLORI INFECTION, Gastroenterology, 112(4), 1997, pp. 275-275

Authors: GOLDSCHMIDTCLERMONT PJ SCHULMAN SP BRAY PF CHANDRA NC GRIGORYEV D DISE KR SAGAR M FOX RJ COLEMAN LD RICHARDSON C DORSEY FC DUMEE C KITT MM OUYANG P BAUGHMAN KL GERSTENBLITH G
Citation: Pj. Goldschmidtclermont et al., REFINING THE TREATMENT OF WOMEN WITH UNSTABLE ANGINA - A RANDOMIZED, DOUBLE-BLIND, COMPARATIVE SAFETY AND EFFICACY EVALUATION OF INTEGRELIN(TM) VERSUS ASPIRIN IN THE MANAGEMENT OF UNSTABLE ANGINA, Clinical cardiology, 19(11), 1996, pp. 869-874

Authors: CHANG M TYBRING G DAHL ML GOTHARSON E SAGAR M SEENSALU R BERTILSSON L
Citation: M. Chang et al., INTERPHENOTYPE DIFFERENCES IN DISPOSITION AND EFFECT ON GASTRIN-LEVELS OF OMEPRAZOLE - SUITABILITY OF OMEPRAZOLE AS A PROBE FOR CYP2C19, British journal of clinical pharmacology, 39(5), 1995, pp. 511-518

Authors: WEINBERG WC AZZOLI CG WU AJ SAGAR M MORGAN DL YUSPA SH
Citation: Wc. Weinberg et al., RECONSTITUTION OF P53-NULL KERATINOCYTE CELL-LINES WITH TEMPERATURE-SENSITIVE P53 - A MODEL FOR EXPLORING THE ROLE OF P53 IN EPIDERMAL BIOLOGY, Journal of investigative dermatology, 104(4), 1995, pp. 599-599

Authors: SEENSALU R IWARZON M JANCZEWSKA I HAMMARLUND B OKSANEN A SAGAR M
Citation: R. Seensalu et al., DOSE-RESPONSE COMPARISON OF LANSOPRAZOLE AND OMEPRAZOLE ON 24-HOUR GASTRIC-ACIDITY AND PLASMA GASTRIN IN HEALTHY-VOLUNTEERS, Gastroenterology, 108(4), 1995, pp. 215-215
Risultati: 1-9 |